Warning Letter Wednesday involves CBD in an OTC topical (hand sanitizer) and further defines FDA’s position regarding CBD as an active or inactive ingredient in OTC drugs. There are also ...

Today’s Warning Letter Wednesday is cringeworthy but also contains learning lessons for product marketers and developers. The product is a vape that contains caffeine, is labeled as a supplement, makes ...

High risk words should be avoided in all forms of marketing. The words “inflammation” or “anti-inflammatory” is being referenced in many warning letters. Read the full warning letter here. If truthful ...

Step #1 in reducing online marketing risk is removing high-risk “buzzwords”. These include Alzheimer’s, cancer, diabetes, PTSD, opioid support, depression, and of course COVID. Other “buzzwords” include pain, anxiety, inflammation, ...

Implying “Clinically Proven” or even “Clinically Studied” is high risk. This is a trend to watch out for. We are seeing references to “clinically proven” types of claims showing up ...

Affiliate marketers continue to be scrutinized for making claims. A few years ago, affiliate warning letters were nearly nonexistent. Now regulators are savvy and are no longer tolerating claims where ...

The FDA is starting to crack down on unsubmitted NDI’s. Today’s Warning Letter Wednesday reviews a recent hordenine warning letter. Hordenine and higenamine warning letters also include high risk disease ...

Ingredient descriptions are considered marketing claims when used to sell a product. Today’s Warning Letter Wednesday highlights this common marketing mistake. This is an example of a well-intentioned writer and ...